Surgepays Inc (NASDAQ: SURG) closed the day trading at $4.55 up 10.98% from the previous closing price of $4.10. In other words, the price has increased by $+0.4500 from its previous closing price. On the day, 892975 shares were traded.
Ratios:
For a better understanding of SURG, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.00 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.77. For the most recent quarter (mrq), Quick Ratio is recorded 1.91 and its Current Ratio is at 2.63. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.03.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 15 ’23 when Cox Kevin Brian bought 5,200 shares for $4.72 per share. The transaction valued at 24,544 led to the insider holds 4,507,894 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SURG now has a Market Capitalization of 87.93M and an Enterprise Value of 78.75M. As of this moment, Surgepays’s Price-to-Earnings (P/E) ratio for their current fiscal year is 3.23. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.64 while its Price-to-Book (P/B) ratio in mrq is 2.32. Its current Enterprise Value per Revenue stands at 0.57 whereas that against EBITDA is 3.92.
Stock Price History:
Over the past 52 weeks, SURG has reached a high of $9.23, while it has fallen to a 52-week low of $3.65. The 50-Day Moving Average of the stock is 6.8383, while the 200-Day Moving Average is calculated to be 5.9089.
Shares Statistics:
Over the past 3-months, SURG traded about 859.72K shares per day on average, while over the past 10 days, SURG traded about 1.3M shares per day. A total of 14.40M shares are outstanding, with a floating share count of 12.95M. Insiders hold about 32.88% of the company’s shares, while institutions hold 7.05% stake in the company. Shares short for SURG as of Feb 29, 2024 were 1.86M with a Short Ratio of 2.17, compared to 1.92M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 10.98% and a Short% of Float of 16.48%.
Earnings Estimates
Current recommendations for the stock of the company come from 1 analysts. On average, analysts expect EPS of $0.29 for the current quarter, with a high estimate of $0.29 and a low estimate of $0.29, while EPS last year was $0.31. The consensus estimate for the next quarter is $0.24, with high estimates of $0.24 and low estimates of $0.24.
Analysts are recommending an EPS of between $1 and $1 for the fiscal current year, implying an average EPS of $1. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
Revenue Estimates
1 analysts predict $32.32M in revenue for the current quarter. It ranges from a high estimate of $32.32M to a low estimate of $32.32M. As of the current estimate, Surgepays Inc’s year-ago sales were $36.5M, an estimated decrease of -11.50% from the year-ago figure. For the next quarter, 1 analysts are estimating revenue of $32.32M, a decrease of -17.20% less than the figure of -$11.50% in the same quarter last year. There is a high estimate of $32.32M for the next quarter, whereas the lowest estimate is $32.32M.
A total of 1 analysts have provided revenue estimates for SURG’s current fiscal year. The highest revenue estimate was $129.28M, while the lowest revenue estimate was $129.28M, resulting in an average revenue estimate of $129.28M. In the same quarter a year ago, actual revenue was $137.14M, down -5.70% from the average estimate.
